227 related articles for article (PubMed ID: 26398150)
21. Filter neuroprotection of a single patent internal carotid artery during transapical aortic valve implantation.
Sarangi S; Bresnahan JF; Bruce CJ; Mario G; Suri RM
J Card Surg; 2015 Mar; 30(3):260-2. PubMed ID: 24750251
[TBL] [Abstract][Full Text] [Related]
22. Coronary Thromboembolism During Transcatheter Aortic Valve Replacement.
Mori Junco R; Domínguez Melcon F; Moreno Yangüela M
Rev Esp Cardiol (Engl Ed); 2015 Oct; 68(10):893. PubMed ID: 25779955
[No Abstract] [Full Text] [Related]
23. Assessment of Access-Related Injury During Transcatheter Aortic Valve Implantation: Current Issues and Future Directions.
Lareyre F; Raffort J; Bourlon F; Mialhe C
Angiology; 2018 Aug; 69(7):561-563. PubMed ID: 28786712
[No Abstract] [Full Text] [Related]
24. Editorial: Cardiogenic shock in severe aortic stenosis: Is it "urgent" TAVR era?
Tamburino C
Cardiovasc Revasc Med; 2023 Oct; 55():8-9. PubMed ID: 37308352
[No Abstract] [Full Text] [Related]
25. Kounis syndrome presenting with cardiogenic shock.
Tanboğa IH; Karabay CY; Can MM; Akgün T; Güler A; Turkylmaz E; Ozveren O; Kaymaz C
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):833-6. PubMed ID: 20543709
[No Abstract] [Full Text] [Related]
26. Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves.
Schwietz T; Behjati S; Gafoor S; Seeger F; Doss M; Sievert H; Zeiher AM; Fichtlscherer S; Lehmann R
EuroIntervention; 2015 Apr; 10(12):1468-73. PubMed ID: 24970670
[TBL] [Abstract][Full Text] [Related]
27. Extrinsic compression of the left main coronary artery by a contained aortic annular rupture following trans-catheter aortic valve implantation.
Erez A; Barbash I; Spiegelstein D; Kogan A; Hamdan A; Shinfeld A; Preisman S; Segev A
Cardiovasc Revasc Med; 2015; 16(5):313-6. PubMed ID: 26100974
[TBL] [Abstract][Full Text] [Related]
28. Combined percutaneous coronary intervention and transcatheter aortic valve implantation in cardiogenic shock.
Steude JS; Abdel-Wahab M; Schubring M; Richardt G
J Heart Valve Dis; 2013 Nov; 22(6):824-7. PubMed ID: 24597404
[TBL] [Abstract][Full Text] [Related]
29. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
30. How should I treat a cardiac arrest during transcatheter aortic valve implantation?
Leroux L; Seguy B; Labrousse L; Casassus F; Dijos M; Dos-Santos P; Lange R; Bleiziffer S; Vranckx P; Price S
EuroIntervention; 2014 Sep; 10(5):648-50. PubMed ID: 24642525
[No Abstract] [Full Text] [Related]
31. Assessment of Fibrin Polymerization During Bivalirudin Anticoagulation for Transcatheter Aortic Valve Replacement.
Wipfli C; Fitzpatrick MV; Fitzpatrick JK; Taylor BS; Tanaka KA
J Cardiothorac Vasc Anesth; 2017 Aug; 31(4):e65-e66. PubMed ID: 28583422
[No Abstract] [Full Text] [Related]
32. Transcatheter aortic valve implantation: Anesthetic experience of retrograde transfemoral approach with CoreValve ReValving System.
Chou WH; Wang YC; Huang HH; Cheng HL; Lin YS; Wang MJ; Huang CH
Acta Anaesthesiol Taiwan; 2014 Mar; 52(1):2-5. PubMed ID: 24999211
[TBL] [Abstract][Full Text] [Related]
33. Long-term results of transapical versus transfemoral TAVI in a real world population of 1000 patients with severe symptomatic aortic stenosis.
Schymik G; Würth A; Bramlage P; Herbinger T; Heimeshoff M; Pilz L; Schymik JS; Wondraschek R; Süselbeck T; Gerhardus J; Luik A; Gonska BD; Posival H; Schmitt C; Schröfel H
Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25552563
[TBL] [Abstract][Full Text] [Related]
34. Treatment of cardiogenic shock in severe aortic stenosis with the Edwards INTUITY valve.
Martinelli GL; Braccio M; Cotroneo A; Labriola C; Cassese M
Ann Thorac Surg; 2014 Nov; 98(5):e107-8. PubMed ID: 25441827
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with vascular complications in patients undergoing balloon-expandable transfemoral transcatheter aortic valve replacement via open versus percutaneous approaches.
Kadakia MB; Herrmann HC; Desai ND; Fox Z; Ogbara J; Anwaruddin S; Jagasia D; Bavaria JE; Szeto WY; Vallabhajosyula P; Li R; Menon R; Kobrin DM; Giri J
Circ Cardiovasc Interv; 2014 Aug; 7(4):570-6. PubMed ID: 25027520
[TBL] [Abstract][Full Text] [Related]
36. [Implantation transfemoral aortic valve Edwards SAPIEN XT in a patient with extreme tortuous aorta].
Martín-Hernández P; Hernández-Antolín R; García-Fernández E
Arch Cardiol Mex; 2014; 84(2):138-40. PubMed ID: 24831431
[No Abstract] [Full Text] [Related]
37. Brachiocephalic artery access in transcatheter aortic valve implantation: a valuable alternative: 3-year institutional experience.
Philipsen TE; Collas VM; Rodrigus IE; Salgado RA; Paelinck BP; Vrints CM; Bosmans JM
Interact Cardiovasc Thorac Surg; 2015 Dec; 21(6):734-40. PubMed ID: 26395943
[TBL] [Abstract][Full Text] [Related]
38. Combined etiology of anaphylactic cardiogenic shock: amiodarone, epinephrine, cardioverter defibrillator, left ventricular assist devices and the Kounis syndrome.
Kounis NG; Soufras GD; Davlouros P; Tsigkas G; Hahalis G
Ann Card Anaesth; 2015; 18(2):261-4. PubMed ID: 25849705
[TBL] [Abstract][Full Text] [Related]
39. A suspected case of coronary vasospasm induced by anaphylactic shock caused by rocuronium-sugammadex complex.
Okuno A; Matsuki Y; Tabata M; Shigemi K
J Clin Anesth; 2018 Aug; 48():7. PubMed ID: 29660702
[No Abstract] [Full Text] [Related]
40. Comparison of 30-Day Outcomes of Transfemoral Versus Transapical Approach for Transcatheter Aortic Valve Replacement: A Single-Center US Experience.
Murarka S; Lazkani M; Neihaus M; Boggess M; Morris M; Gellert G; Fang HK; Pershad A
Ann Thorac Surg; 2015 May; 99(5):1539-44. PubMed ID: 25754964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
